Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Carthera logo — Advanced Brain Therapy

Carthera

Advanced Brain Therapy

Founded 2010 France France 35 employees Series B Total: $71.30M Biotechnology, Health Care +2

General Information

Company Name Carthera
Founded Year 2010
Location France France +2
Employees 35
Industries Biotechnology, Health Care, Health and Wellness +1
Funding Stage Series B
Social

Get notified when Carthera moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Carthera

Carthera is a French medtech startup founded in 2010, specializing in advanced brain therapy. The company has developed the SonoCloud, a proprietary device that utilizes ultrasound to temporarily increase the permeability of blood vessels in the brain. This breakthrough technology aims to enhance the therapeutic efficacy of both new and existing therapies for treating a wide range of severe brain disorders, including oncology indications (such as glioblastoma and brain metastasis) as well as neurodegenerative diseases like Alzheimer's Disease and ALS. Carthera's innovative products are currently in clinical or preclinical evaluation and have not yet received FDA or CE approval. The company recently secured a significant €4.50M Series B investment on 11 December 2023, with the backing of notable investors including Supernova Invest, Unorthodox Ventures, Saint-Genys, and BOUSCAS. The startup's focus on cutting-edge medical devices for treating severe brain disorders presents an exciting opportunity for investors looking to support groundbreaking advancements in the biotechnology and healthcare industries.

Taxonomy: Medical Device Innovation, Neurotechnology, Ultrasound Therapy, Brain Disorder Treatment, Biomedical Engineering, Clinical-stage Medtech, Therapeutic Ultrasound, Neuro-oncology, Neurosurgical Devices, Blood-Brain Barrier Technology

Services & Products

Development of innovative ultrasound-based medical devices for the treatment of severe brain disorders
especially focused on glioblastoma and CNS diseases.

Target Customers

Patients with severe brain disorders such as glioblastoma brain metastases and Alzheimer’s Disease healthcare professionals specializing in neuro-oncology and biopharmaceutical companies seeking innovative drug delivery solutions for brain diseases.

Funding Rounds & Investors (8)

View All
Funding Stage Amount Investors Lead Investors Date
Series B •••••• 4
Investor Investor
•••• •••• 		11 Dec 2023
Series B •••••• 4
Investor Investor Investor Investor
27 Jun 2023
Grant •••••• 1
Investor
14 Sep 2020
Venture Round •••••• 1
Investor
14 Sep 2020
Series B •••••• 4
Investor Investor
•••• •••• 		12 Dec 2018

View All 8 Funding Rounds

Latest News

View All
Carthera secures additional €4.5M for innovative medtech to treat brain disorders — Tech
Carthera secures additional €4.5M for innovative medtech to treat brain disorders
Tech Jan 23, 2024

Carthera Alternatives & Competitors

Carthera vs
Cordance Medical
Cordance Medical United States

Non-invasive therapy delivery system for central nervous system diseases

Seed
10 employees
Health Care, Health and Wellness
Compare Carthera vs Cordance Medical
Carthera vs
SonoClear AS
SonoClear AS Norway

Improving diagnostic accuracy in ultrasound guided interventions

Series Unknown
7 employees
Entertainment, Health Care
Compare Carthera vs SonoClear AS
Carthera vs
ICONEUS
ICONEUS France

Delivering functional ultrasound (fUS) imaging solutions to help scientists understand the Brain fun...

Series Unknown
38 employees
Biotechnology, Health Care
Compare Carthera vs ICONEUS

FAQ About Carthera

Advanced Brain Therapy
Carthera was founded in 2010.
Carthera is headquartered in France.
Carthera operates in the following industries: Biotechnology, Health Care, Health and Wellness, Medical Devices.
Carthera has approximately 35 employees.
Carthera has completed 8 funding rounds, raising a total of $71.30M. The latest funding stage is Series B.
Carthera offers: Development of innovative ultrasound-based medical devices for the treatment of severe brain disorders, especially focused on glioblastoma and CNS diseases..
Top alternatives and competitors to Carthera include Cordance Medical, SonoClear AS, ICONEUS, Evanesc Therapeutics, NeuraSignal. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Carthera and Cordance Medical are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Carthera and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy